Both in Pharmaceuticals
Abbott Laboratories vs Regeneron Pharmaceuticals
Over the past year ABT returned −14.1% and REGN returned +42.4%; their daily moves had a correlation of 0.20.
ABT −14.1% REGN +42.4%Growth of $1, one year, split-adjusted
| Metric | ABT | REGN |
|---|---|---|
| Price | $106.20 | $927.89 |
| Market cap | $183.77B | $95.99B |
| Today | +1.56% | +13.33% |
| 1 month | +9.8% | +26.3% |
| 6 months | +18.7% | +32.3% |
| Year to date | −15.2% | +20.2% |
| 1 year | −14.7% | +42.1% |
| Revenue growth (YoY) | +13.0% | +36.3% |
| Gross margin | 57.7% | 88.8% |
| Net margin | 7.4% | 38.1% |
| P/E (TTM) | 33.9× | 19.9× |
| Price / sales | 3.9× | 5.7× |
| Net cash | -$27.00B | $6.59B |
| Dividend yield | 2.37% | 0.41% |
| Volatility (60d) | 21.3% | 37.0% |
| Short % of float | 1.0% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).